Shanghai, China

Dongqi Chen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Dongqi Chen: Innovator in Cellular Therapeutics**

Introduction

Dongqi Chen is a distinguished inventor based in Shanghai, China, recognized for his contributions to the field of cellular therapeutics. With a significant portfolio of three patents, he is dedicated to advancing medical treatments, particularly for cancers affecting the digestive system.

Latest Patents

Among his latest innovations is the patent for “Anti-GCC antibody and CAR thereof for treating digestive system cancer.” This groundbreaking work pertains to methods and compositions that involve administering effective amounts of a cell composition to treat patients with digestive tract cancer. The innovative approach combines a first population of cells with a CAR binding to an antigen found on white blood cells and a second population binding to GCC.

Another notable patent includes “Modified TCR and uses thereof,” which describes an engineered cell containing a modified TCR-CD3 complex. This invention links various chains of the TCR-CD3 complex to co-stimulatory signaling domains, enhancing the effectiveness of cancer treatments.

Career Highlights

Dongqi Chen has collaborated with several organizations throughout his career, including Innovative Cellular Therapeutics Holdings, Ltd. and Innovative Cellular Therapeutics, Inc. His work at these institutions has enabled significant advancements in the treatment of cancer, leveraging cutting-edge technologies to improve patient outcomes.

Collaborations

In his endeavors, Dongqi Chen has worked alongside esteemed colleagues, including Chengfei Pu and Xiaogang Shen. Their collective expertise has played a pivotal role in furthering their research and in the development of innovative therapeutic strategies.

Conclusion

Dongqi Chen continues to be a prominent figure in the domain of cellular therapeutics, with his innovative patents paving the way for new approaches to treating challenging medical conditions. His commitment to research and collaboration exemplifies the spirit of innovation that drives progress in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…